GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET FORECAST 2024-2032
世界の疫学における人工知能（AI）市場予測 2024-2032年
Global Artificial Intelligence (AI) in Epidemiology Market by Deployment (on-premise, Web-based, Cloud-based) Market by Application (Infection Prediction & Forecasting, Disease & Syndromic Surveillance, Monitoring Population Health & Incidence/ Prevalence) Market by End Use (Government & State Agencies, Research Labs, Pharmaceutical & Biotechnology Companies, Healthcare Providers) by Geography
The global artificial intelligence (AI) in epidemiology market is forecasted to generate a CAGR of 27.33% over the projection years of 2024-2032.
世界の疫学市場における人工知能 (AI) は、2024 年から 2032 年の予測年にわたって 27.33% の CAGR を生み出すと予測されています。
Key drivers facilitating the market’s growth include the early detection and surveillance of disease outbreaks, the growing need for predictive modeling to forecast disease trends, and data availability for epidemiological research.
REPORT SYNOPSIS
| REPORT SCOPE | DETAILS |
|---|---|
| Market Forecast Years | 2024-2032 |
| Base Year | 2023 |
| Market Historical Years | 2018-2022 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Deployment, Application, and End Use |
| Geographies Analyzed | North America, Europe, Asia-Pacific, and Rest of World |
| Companies Analyzed | Cerner Corporation, Cognizant, eClinical Works Inc, Alphabet Inc, Intel Corporation, Epic Systems Corporation, Microsoft Corporation, Meditech, Komodo Health, Siemens Healthineers, Bayer Healthcare, SAS Institute, Cardiolyse, Predixion Healthcare (Jvion LLC) |